What Foundayo costs, and what the savings card actually covers

Before you read. This page is educational, not a quote, not an offer, and not medical or financial advice. It does not tell you whether to start, continue, or stop any medicine — that belongs to you and your prescriber. Every price below was verified against the manufacturer and Medicare pages linked at the bottom on 6 August 2026. Drug pricing changes without notice, so check those pages and your own plan before you plan around a number.

Quick answer

Foundayo does not have one price. It has four, and which one applies to you is decided almost entirely by what kind of insurance you hold. The manufacturer's published list price is $649 per month at every dose strength. If you pay cash through Lilly's own pharmacy, the published self-pay price runs from $149 to $349 per month depending on the dose. If you have commercial insurance that covers Foundayo, the savings card advertises as little as $25 per month — capped. And if you have Medicare Part D and clear the clinical criteria, the Medicare GLP-1 Bridge programme puts it at no more than $50 per month.

The gap between $25 and $649 is not a discount you negotiate. It is a set of eligibility gates, each with printed limits, and the rest of this page is those limits.

Track your doses in Takely

What is the list price of Foundayo?

$649 for a one-month supply, the same at every tablet strength, according to Lilly's own pricing information page.

That figure is the wholesale acquisition cost — what the manufacturer charges wholesalers. Lilly says so plainly on that page, and adds that what patients actually pay at the pharmacy depends on their insurer's out-of-pocket rules, the pharmacy, and any discount programmes they qualify for.

So treat $649 as the ceiling and the reference point, not the number on your receipt. It is useful for exactly one thing: understanding what the other three prices are discounted from. When the government's TrumpRx listing advertises "up to 77% off" on Foundayo, that percentage is measured against this list price, and it lands where you would expect — $149 is a little under a quarter of $649.

Why this page carries a date. Nothing on it is a stable fact. Self-pay tiers, savings card caps and Medicare criteria are all set by the parties who publish them and can be revised at any time — the savings card terms say so explicitly. Everything here was checked on 6 August 2026 and is scheduled for re-verification each quarter. If you are reading this well after that date, open the linked pages instead of trusting this one.

What does Foundayo cost without insurance?

This is the most-asked version of the question, and it has a published answer. Lilly sells Foundayo direct through LillyDirect, and the self-pay prices listed on that page as of 6 August 2026 are:

Dose strength	Published self-pay price
0.8 mg	$149 per month
2.5 mg	$199 per month
5.5 mg	$299 per month
9 mg	$299 per month
14.5 mg	$299 per month when refilled within 45 days; otherwise $349
17.2 mg	$299 per month when refilled within 45 days; otherwise $349

Three things about that table deserve more attention than they usually get.

The prices are written as "starting at." Lilly's page states each figure that way, and attaches "terms and conditions apply" to all of them. It is a published programme price, not a guaranteed one.

The top two doses carry a refill condition. The $299 rate on 14.5 mg and 17.2 mg is tied to refilling within 45 days; miss that window and the page shows $349. That is a real $50 swing driven by timing rather than by anything clinical, and it is the one line on this page that a calendar can actually protect you from.

Self-pay is not the same as uninsured. People with insurance that excludes weight-management drugs — a very common exclusion — end up on the same self-pay path as people with no coverage at all. If your plan's formulary does not list Foundayo, the savings card in the next section will not help you either; it requires coverage, not merely a commercial card.

Foundayo is also listed on TrumpRx, the federal price-comparison site, which advertises "up to 77% off" and then hands the transaction to LillyDirect. As of 6 August 2026 that listing did not publish per-strength prices on its own page — it routes you to Lilly to see them. It is a different front door to the same pricing, not a separate cheaper channel.

What does the Foundayo savings card actually cover?

The advertised headline is "as little as $25 per month." The word doing the work is eligible, and the terms define it narrowly.

Term	What the card states
Copay	As little as $25 for a 1-month, 2-month, or 3-month fill
Who qualifies	People with commercial drug insurance that covers Foundayo, plus a prescription for an FDA-approved use
Maximum saving	Up to $100 per 1-month fill, $200 per 2-month fill, $300 per 3-month fill
Annual cap	Up to $1,000 per calendar year
Fill limit	Up to 10 prescription fills per calendar year
Excluded	Government beneficiaries — Medicare, Medicaid, Medicare Part D, Medicare Advantage, TRICARE, VA, DoD, Medigap
Stability	Lilly states it may terminate, rescind, revoke or amend the criteria and terms at its sole discretion

Read the caps together and a pattern appears. The card is capped at $100 of help per monthly fill and $1,000 across a year. That is enough to turn a modest copay into $25, and not enough to turn a large one into $25 — if your plan's coinsurance leaves you owing $300, a $100 maximum saving leaves you at $200, not $25. The $25 headline describes the floor the card can reach, not the price it delivers to everyone holding one.

The ten-fill annual limit is the other quiet one. Twelve months of continuous treatment is more than ten fills, so the card does not cover a full calendar year of monthly refills. Multi-month fills change that arithmetic, which is presumably why the terms price them separately.

None of this makes the card bad. It makes it a bounded benefit that has to be read alongside your own plan documents, and it is worth asking the pharmacy to run the card and your insurance together before the first fill rather than after.

Dose steps drive the price. Takely keeps a private record of which dose you are on and when it changed — the same information that decides which self-pay tier applies and what your next appointment needs to know. Open Takely →

What if you have Medicare?

Medicare beneficiaries are excluded from the savings card, and routed instead to the Medicare GLP-1 Bridge programme.

Under that programme, Lilly's page states that eligible Medicare Part D patients may get Foundayo for no more than $50 per month, with the Foundayo route starting 1 July 2026. Lilly's April 2026 launch announcement gave the same date and figure. The programme also covers Zepbound KwikPen, and Lilly's page notes that the Zepbound single-dose vial and single-dose pen are not included.

The eligibility conditions published on that page are specific:

You must be an adult, 18 or over.
You must be covered through Medicare Part D — either a standalone drug plan or a Medicare health plan that includes drug coverage.
The prescription must be for chronic weight management, not for type 2 diabetes.
You must meet the programme's BMI and clinical criteria, and a prior authorisation is required.

Two exclusions are easy to miss. A Zepbound prescription written for moderate to severe obstructive sleep apnoea with obesity does not qualify, and neither does a prescription written for type 2 diabetes or for fatty liver disease. The programme is scoped to weight management specifically. Lilly's page shows the programme as valid from July 2026 through December 2027.

Medicare.gov publishes its own fact sheet on the Bridge programme. If you are on Part D, that is the document to read before you read anything a manufacturer publishes about it, and it is linked at the bottom of this page.

What about Medicaid, TRICARE, or VA coverage?

The savings card excludes all of them by name, and the Medicare Bridge is Part D only. That leaves plan-specific coverage as the only path, and it genuinely varies — state Medicaid programmes differ from one another on whether they cover weight-management drugs at all.

We are not going to invent a number for those situations. The honest answer is that your plan's own formulary is the authority, and a pharmacist can usually run a test claim faster than a phone tree can answer.

Why the dose you are on changes the price

Foundayo escalates in steps — 0.8 mg, then 2.5 mg, then 5.5 mg, and upward from there, with at least 30 days on each dose before the next increase. We cover that schedule in what Foundayo is and how it is dosed.

The consequence for cost is that a self-pay price is not a fixed monthly bill. Month one at $149 and month four at $299 are the same treatment at different points in a titration. If you are budgeting, budget from the tier you expect to sit on rather than the one you start on — and remember that the label leaves the upper steps as a decision between you and your prescriber, not a fixed destination.

That also means the dates of your dose changes are worth recording. They determine which price tier you are in, and they are one of the things a prescriber asks about at follow-up. Takely can keep the dose-step dates in one place without a spreadsheet.

How does this compare with the other GLP-1 pill?

Briefly, because the comparison is often the real question behind "how much does Foundayo cost."

At the manufacturer's published self-pay rates checked in the last week of July 2026, Wegovy tablets ran $149 for the starting doses and $299 at the 9 mg and 25 mg doses, with the injection pen at $349 at maintenance. Foundayo's self-pay ladder starts at the same $149 and reaches $299 to $349 at the top strengths. On published self-pay pricing the two oral products are close; we set out the Wegovy figures and their conditions in the Wegovy pill and pen self-pay prices.

What the self-pay comparison cannot tell you is what you will pay, because that turns on formulary placement, prior authorisation, and copay tiers — three things that differ per plan and change at renewal. It also has nothing to say about which medicine suits you clinically. That is not a cost question and this is not the page for it.

What we could not verify

Being specific about the gaps is more useful than filling them in.

What a retail pharmacy charges without any programme. Foundayo is sold through US retail pharmacies as well as LillyDirect, but retail cash prices are set per pharmacy and are not published in one place. We have no verified figure and are not estimating one.
Whether a manufacturer patient-assistance programme covers Foundayo. We could not confirm one for this product on a manufacturer page, so we are not describing terms for it.
Typical insured copays. There is no reliable average. Copay tiers, coinsurance percentages and weight-management exclusions vary too much between plans for a number to mean anything.
How long any of these prices last. Every source here reserves the right to change its terms.

Frequently asked questions

How much does Foundayo cost per month?

It depends entirely on how you pay. The manufacturer's published list price is $649 per month at every strength. Published LillyDirect self-pay prices run $149 to $349 per month by dose. Eligible commercially insured patients may pay as little as $25 per month with the savings card, subject to caps. Eligible Medicare Part D patients may pay no more than $50 per month through the Medicare GLP-1 Bridge programme. All figures verified 6 August 2026.

How much does Foundayo cost without insurance?

Lilly's published self-pay prices as of 6 August 2026 are $149 per month for 0.8 mg, $199 for 2.5 mg, $299 for 5.5 mg and 9 mg, and $299 for 14.5 mg and 17.2 mg when refilled within 45 days, otherwise $349. Each is listed as a "starting at" price with terms and conditions attached.

Is the Foundayo savings card really $25 a month?

$25 is the floor the card can reach, not a flat price. It requires commercial drug insurance that covers Foundayo, and the savings are capped at up to $100 per 1-month fill and $1,000 per calendar year, across a maximum of 10 fills. If your plan leaves you owing more than the cap can absorb, you pay the difference.

Can I use the Foundayo savings card with Medicare or Medicaid?

No. The terms exclude government beneficiaries by name, including Medicare, Medicaid, Medicare Part D, Medicare Advantage, TRICARE, VA, DoD and Medigap. Medicare Part D patients are directed instead to the Medicare GLP-1 Bridge programme.

How do I get Foundayo for $50 a month on Medicare?

Through the Medicare GLP-1 Bridge programme, which Lilly's page says applies to Foundayo from 1 July 2026. It requires Medicare Part D coverage, a prescription for chronic weight management, adult age, prior authorisation, and meeting the programme's BMI and clinical criteria. Read the Medicare.gov fact sheet and speak to your prescriber's office about the prior authorisation.

Does the price change as my dose goes up?

On the published self-pay ladder, yes — the lower starting strengths are cheaper than the maintenance strengths. Your dose is a clinical decision made with your prescriber, and it should not be made around a price tier.

Why does the top dose cost more if I refill late?

Lilly's LillyDirect page ties the $299 rate on 14.5 mg and 17.2 mg to refilling within 45 days, and shows $349 otherwise. It is a programme condition, not a clinical one.

Primary sources and further reading

Every price on this page was verified on 6 August 2026 against the sources above. These are published US programme prices, not quotes, and they are reviewed quarterly. Check the current pages and your own plan, and ask your clinician or pharmacist about your own prescription.